Significant Ownership of Merck & Co., Inc.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Merck & Co., Inc. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Kelly Grez - Kelly Grez/Corporate Secretary
- Manager location
- Rahway, NJ
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Merck & Co., Inc. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Merck & Co., Inc.
Significant Ownership of Merck & Co., Inc.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EVAX | Evaxion Biotech A/S | American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share | 20% | $105,531,938 | 63,004,142 | Merck & Co., Inc. | 31 Jan 2025 | ||
| PSNL | Personalis, Inc. | Common Stock, $0.0001 par value per share | 16% | $53,792,132 | 14,044,943 | Merck & Co., Inc. | 19 Dec 2024 |
Schedules 13D/G Reported by Merck & Co., Inc.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.